 By John Vandermosten, CFA NASDAQ:LPCN READ THE FULL LPCN RESEARCH REPORT 2019 Operational and Financial Results On March 13, 2020 Lipocine NASDAQ:LPCN filed its fiscal year 2019 10-K and posted its earnings release for the twelve-month period ending December 31, 2019. The company reported 165,000 in revenues and a net loss per share of 0.50 compared to prior year revenues of 428,000 and 